

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.69863167 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.69863167 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.42325569 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.42325569 |
| 5 | regulation of somitogenesis (GO:0014807) | 6.41952180 |
| 6 | plasma membrane repair (GO:0001778) | 6.07103858 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.04045659 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.87869553 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 5.63178597 |
| 10 | hair cycle (GO:0042633) | 5.56398627 |
| 11 | molting cycle (GO:0042303) | 5.56398627 |
| 12 | indole-containing compound catabolic process (GO:0042436) | 5.49096340 |
| 13 | indolalkylamine catabolic process (GO:0046218) | 5.49096340 |
| 14 | tryptophan catabolic process (GO:0006569) | 5.49096340 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.38817470 |
| 16 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.34594767 |
| 17 | kynurenine metabolic process (GO:0070189) | 5.33310933 |
| 18 | tryptophan metabolic process (GO:0006568) | 5.16809169 |
| 19 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.14798557 |
| 20 | sulfur amino acid catabolic process (GO:0000098) | 5.08521498 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.05539896 |
| 22 | detection of molecule of bacterial origin (GO:0032490) | 5.04048055 |
| 23 | urea cycle (GO:0000050) | 5.01604879 |
| 24 | urea metabolic process (GO:0019627) | 5.01604879 |
| 25 | cysteine metabolic process (GO:0006534) | 4.97729321 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.96550340 |
| 27 | protein carboxylation (GO:0018214) | 4.96550340 |
| 28 | glyoxylate metabolic process (GO:0046487) | 4.96002915 |
| 29 | reverse cholesterol transport (GO:0043691) | 4.82748763 |
| 30 | complement activation, alternative pathway (GO:0006957) | 4.81429678 |
| 31 | regulation of protein activation cascade (GO:2000257) | 4.81334019 |
| 32 | positive regulation of digestive system process (GO:0060456) | 4.69552711 |
| 33 | sulfation (GO:0051923) | 4.65508976 |
| 34 | bile acid metabolic process (GO:0008206) | 4.64133944 |
| 35 | negative regulation of fibrinolysis (GO:0051918) | 4.60210683 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.58545450 |
| 37 | regulation of cholesterol esterification (GO:0010872) | 4.57019531 |
| 38 | nitrogen cycle metabolic process (GO:0071941) | 4.53943947 |
| 39 | replicative senescence (GO:0090399) | 4.52606576 |
| 40 | lysine catabolic process (GO:0006554) | 4.52346538 |
| 41 | lysine metabolic process (GO:0006553) | 4.52346538 |
| 42 | regulation of fibrinolysis (GO:0051917) | 4.51907928 |
| 43 | regulation of complement activation (GO:0030449) | 4.51747102 |
| 44 | plasma lipoprotein particle remodeling (GO:0034369) | 4.45149646 |
| 45 | protein-lipid complex remodeling (GO:0034368) | 4.45149646 |
| 46 | macromolecular complex remodeling (GO:0034367) | 4.45149646 |
| 47 | amino-acid betaine metabolic process (GO:0006577) | 4.41162743 |
| 48 | phospholipid efflux (GO:0033700) | 4.39630581 |
| 49 | regulation of DNA damage checkpoint (GO:2000001) | 4.37636677 |
| 50 | serine family amino acid catabolic process (GO:0009071) | 4.37425282 |
| 51 | aromatic amino acid family metabolic process (GO:0009072) | 4.31348714 |
| 52 | homocysteine metabolic process (GO:0050667) | 4.24741093 |
| 53 | tyrosine metabolic process (GO:0006570) | 4.21047879 |
| 54 | positive regulation of systemic arterial blood pressure (GO:0003084) | 4.20975285 |
| 55 | protein prenylation (GO:0018342) | 4.20511606 |
| 56 | prenylation (GO:0097354) | 4.20511606 |
| 57 | alpha-amino acid catabolic process (GO:1901606) | 4.19171861 |
| 58 | extracellular matrix assembly (GO:0085029) | 4.16844291 |
| 59 | cellular ketone body metabolic process (GO:0046950) | 4.10147231 |
| 60 | cholesterol efflux (GO:0033344) | 4.06651321 |
| 61 | negative regulation of systemic arterial blood pressure (GO:0003085) | 4.05502393 |
| 62 | ethanol oxidation (GO:0006069) | 4.04570146 |
| 63 | negative regulation of sterol transport (GO:0032372) | 4.02850653 |
| 64 | negative regulation of cholesterol transport (GO:0032375) | 4.02850653 |
| 65 | acylglycerol homeostasis (GO:0055090) | 3.98198938 |
| 66 | triglyceride homeostasis (GO:0070328) | 3.98198938 |
| 67 | low-density lipoprotein particle remodeling (GO:0034374) | 3.97833238 |
| 68 | bile acid and bile salt transport (GO:0015721) | 3.97524951 |
| 69 | plasma lipoprotein particle assembly (GO:0034377) | 3.95196260 |
| 70 | T cell mediated immunity (GO:0002456) | 3.95004295 |
| 71 | indolalkylamine metabolic process (GO:0006586) | 3.93761971 |
| 72 | plasma lipoprotein particle clearance (GO:0034381) | 3.92488357 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 3.89675020 |
| 74 | glycine metabolic process (GO:0006544) | 3.87938442 |
| 75 | imidazole-containing compound metabolic process (GO:0052803) | 3.85990330 |
| 76 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.85186505 |
| 77 | glutamate metabolic process (GO:0006536) | 3.85040977 |
| 78 | coenzyme catabolic process (GO:0009109) | 3.84112150 |
| 79 | drug transmembrane transport (GO:0006855) | 3.83361938 |
| 80 | short-chain fatty acid metabolic process (GO:0046459) | 3.80796535 |
| 81 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.76199248 |
| 82 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.76161921 |
| 83 | cellular modified amino acid catabolic process (GO:0042219) | 3.75333155 |
| 84 | desmosome organization (GO:0002934) | 3.75317837 |
| 85 | serine family amino acid biosynthetic process (GO:0009070) | 3.74295804 |
| 86 | cellular biogenic amine catabolic process (GO:0042402) | 3.74038781 |
| 87 | amine catabolic process (GO:0009310) | 3.74038781 |
| 88 | negative regulation of peptidyl-lysine acetylation (GO:2000757) | 3.72711613 |
| 89 | serine family amino acid metabolic process (GO:0009069) | 3.71540462 |
| 90 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.69976161 |
| 91 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.69370305 |
| 92 | blood coagulation, intrinsic pathway (GO:0007597) | 3.68299972 |
| 93 | microglial cell activation (GO:0001774) | 3.67988880 |
| 94 | benzene-containing compound metabolic process (GO:0042537) | 3.67870263 |
| 95 | peristalsis (GO:0030432) | 3.66239997 |
| 96 | positive regulation by symbiont of host defense response (GO:0052509) | 3.65178539 |
| 97 | modulation by symbiont of host defense response (GO:0052031) | 3.65178539 |
| 98 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.65178539 |
| 99 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.65178539 |
| 100 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.65178539 |
| 101 | modulation by symbiont of host immune response (GO:0052553) | 3.65178539 |
| 102 | flavonoid metabolic process (GO:0009812) | 3.62048997 |
| 103 | 2-oxoglutarate metabolic process (GO:0006103) | 3.61905081 |
| 104 | aldehyde catabolic process (GO:0046185) | 3.61531525 |
| 105 | fatty acid beta-oxidation (GO:0006635) | 3.60816910 |
| 106 | phospholipid homeostasis (GO:0055091) | 3.60503998 |
| 107 | cellular glucuronidation (GO:0052695) | 3.59356125 |
| 108 | carboxylic acid catabolic process (GO:0046395) | 3.58807120 |
| 109 | organic acid catabolic process (GO:0016054) | 3.58807120 |
| 110 | fatty acid oxidation (GO:0019395) | 3.56033785 |
| 111 | cofactor catabolic process (GO:0051187) | 3.56016573 |
| 112 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.55949392 |
| 113 | plasma lipoprotein particle organization (GO:0071827) | 3.55685747 |
| 114 | drug catabolic process (GO:0042737) | 3.55450903 |
| 115 | protein activation cascade (GO:0072376) | 3.55267455 |
| 116 | monocarboxylic acid catabolic process (GO:0072329) | 3.54415309 |
| 117 | fibrinolysis (GO:0042730) | 3.54257606 |
| 118 | ketone body metabolic process (GO:1902224) | 3.53739950 |
| 119 | complement activation, classical pathway (GO:0006958) | 3.53507839 |
| 120 | complement activation (GO:0006956) | 3.52723100 |
| 121 | fatty acid catabolic process (GO:0009062) | 3.51513169 |
| 122 | lipid oxidation (GO:0034440) | 3.51190582 |
| 123 | carnitine metabolic process (GO:0009437) | 3.50078153 |
| 124 | arginine metabolic process (GO:0006525) | 3.47220087 |
| 125 | drug transport (GO:0015893) | 3.46535976 |
| 126 | protein-lipid complex assembly (GO:0065005) | 3.46314845 |
| 127 | cholesterol homeostasis (GO:0042632) | 3.41277530 |
| 128 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.41275962 |
| 129 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.41275962 |
| 130 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.38967653 |
| 131 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.38967653 |
| 132 | regulation of cell proliferation involved in kidney development (GO:1901722) | 3.36113970 |
| 133 | cardiac muscle adaptation (GO:0014887) | 3.33032033 |
| 134 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.33032033 |
| 135 | muscle hypertrophy in response to stress (GO:0003299) | 3.33032033 |
| 136 | striated muscle atrophy (GO:0014891) | 3.31048043 |
| 137 | labyrinthine layer development (GO:0060711) | 3.26925558 |
| 138 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.26924210 |
| 139 | hemidesmosome assembly (GO:0031581) | 3.23056721 |
| 140 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.20397994 |
| 141 | adrenergic receptor signaling pathway (GO:0071875) | 3.18230066 |
| 142 | negative regulation of multicellular organism growth (GO:0040015) | 3.13477357 |
| 143 | leukotriene biosynthetic process (GO:0019370) | 3.10567715 |
| 144 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.09213022 |
| 145 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.09213022 |
| 146 | striated muscle adaptation (GO:0014888) | 3.07388126 |
| 147 | positive regulation of heart rate (GO:0010460) | 3.03150196 |
| 148 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.99956729 |
| 149 | positive regulation of muscle hypertrophy (GO:0014742) | 2.99956729 |
| 150 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.96622178 |
| 151 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.84287207 |
| 152 | hematopoietic stem cell proliferation (GO:0071425) | 2.83029436 |
| 153 | growth hormone receptor signaling pathway (GO:0060396) | 2.82841502 |
| 154 | cardiac muscle hypertrophy (GO:0003300) | 2.81396070 |
| 155 | regulation of actin filament-based movement (GO:1903115) | 2.80671733 |
| 156 | carbohydrate phosphorylation (GO:0046835) | 2.77260824 |
| 157 | post-anal tail morphogenesis (GO:0036342) | 2.72491632 |
| 158 | positive regulation of fatty acid oxidation (GO:0046321) | 2.71717269 |
| 159 | regulation of hippo signaling (GO:0035330) | 2.68822877 |
| 160 | muscle atrophy (GO:0014889) | 2.67442242 |
| 161 | striated muscle hypertrophy (GO:0014897) | 2.65360810 |
| 162 | negative regulation of protein acetylation (GO:1901984) | 2.65039072 |
| 163 | forebrain neuron development (GO:0021884) | 2.64423916 |
| 164 | regulation of phospholipid biosynthetic process (GO:0071071) | 2.61872674 |
| 165 | negative regulation of platelet activation (GO:0010544) | 2.61623344 |
| 166 | macrophage activation involved in immune response (GO:0002281) | 2.61516317 |
| 167 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.60942620 |
| 168 | cellular response to growth hormone stimulus (GO:0071378) | 2.60345922 |
| 169 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.57150872 |
| 170 | T-helper cell differentiation (GO:0042093) | 2.57150872 |
| 171 | negative regulation of fatty acid transport (GO:2000192) | 2.57064518 |
| 172 | endocardial cushion development (GO:0003197) | 2.56142451 |
| 173 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.55512585 |
| 174 | dermatan sulfate biosynthetic process (GO:0030208) | 2.52446161 |
| 175 | cell differentiation involved in embryonic placenta development (GO:0060706) | 2.50987901 |
| 176 | negative regulation of protein localization to cell surface (GO:2000009) | 2.50838448 |
| 177 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.50137676 |
| 178 | activation of protein kinase A activity (GO:0034199) | 2.49978027 |
| 179 | response to host immune response (GO:0052572) | 2.49072193 |
| 180 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.49072193 |
| 181 | negative regulation of smooth muscle contraction (GO:0045986) | 2.48885244 |
| 182 | macrophage activation (GO:0042116) | 2.48172251 |
| 183 | embryonic camera-type eye morphogenesis (GO:0048596) | 2.48118811 |
| 184 | regulation of metalloenzyme activity (GO:0048552) | 2.45501734 |
| 185 | pyrimidine dimer repair (GO:0006290) | 2.45326554 |
| 186 | skeletal muscle adaptation (GO:0043501) | 2.43878610 |
| 187 | dopamine transport (GO:0015872) | 2.43596410 |
| 188 | regulation of sequestering of triglyceride (GO:0010889) | 2.43192856 |
| 189 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.42086894 |
| 190 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.39365014 |
| 191 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.39191478 |
| 192 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.36891377 |
| 193 | regulation of digestive system process (GO:0044058) | 2.35044959 |
| 194 | extracellular fibril organization (GO:0043206) | 2.34837677 |
| 195 | activation of JUN kinase activity (GO:0007257) | 2.34506120 |
| 196 | fibril organization (GO:0097435) | 2.34368215 |
| 197 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.33039682 |
| 198 | negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147) | 2.32700799 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 8.09418609 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.43964264 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.36211716 |
| 4 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.28371473 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.78119979 |
| 6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 5.33077345 |
| 7 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.94720481 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.64516597 |
| 9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.51046261 |
| 10 | GATA1_22025678_ChIP-Seq_K562_Human | 4.04079394 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.01054223 |
| 12 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.88100418 |
| 13 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.31413040 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.08049068 |
| 15 | TP53_16413492_ChIP-PET_HCT116_Human | 3.02823658 |
| 16 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.97889772 |
| 17 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.15273630 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.13384910 |
| 19 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.10463305 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.02639972 |
| 21 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.5505918 |
| 22 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.97993291 |
| 23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.93110482 |
| 24 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.92207037 |
| 25 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.80237814 |
| 26 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.80008765 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.71337671 |
| 28 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.68607406 |
| 29 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.63621330 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62957938 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.62175970 |
| 32 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.61892151 |
| 33 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.58702269 |
| 34 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.57903426 |
| 35 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.57597628 |
| 36 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.51729903 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48342520 |
| 38 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.47513727 |
| 39 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.47242740 |
| 40 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.46499291 |
| 41 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.45222742 |
| 42 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.44802331 |
| 43 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.44034432 |
| 44 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.42322167 |
| 45 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.41431967 |
| 46 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.39615408 |
| 47 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.38952339 |
| 48 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.38503002 |
| 49 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.38414138 |
| 50 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.37443548 |
| 51 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.36728224 |
| 52 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.35275971 |
| 53 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.31401007 |
| 54 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.31326054 |
| 55 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.30941125 |
| 56 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29209115 |
| 57 | CJUN_26792858_Chip-Seq_BT549_Human | 1.28629624 |
| 58 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.27375946 |
| 59 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.27025477 |
| 60 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.26252320 |
| 61 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.25963942 |
| 62 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.23964323 |
| 63 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.22060282 |
| 64 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.19310988 |
| 65 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.17590664 |
| 66 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.17412576 |
| 67 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.16909577 |
| 68 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.16427237 |
| 69 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13752783 |
| 70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.12804154 |
| 71 | RXR_22108803_ChIP-Seq_LS180_Human | 1.12111117 |
| 72 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.10880890 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10151768 |
| 74 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.09874526 |
| 75 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.08449570 |
| 76 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.07265630 |
| 77 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05917358 |
| 78 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.05011934 |
| 79 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.04566852 |
| 80 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.04566852 |
| 81 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04038509 |
| 82 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.03045465 |
| 83 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02235779 |
| 84 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.01851638 |
| 85 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.01561021 |
| 86 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.00941241 |
| 87 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99357034 |
| 88 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.98857510 |
| 89 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.97570262 |
| 90 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.94083339 |
| 91 | GF1_26923725_Chip-Seq_HPCs_Mouse | 0.93066323 |
| 92 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.92772501 |
| 93 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.91996716 |
| 94 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.91881669 |
| 95 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.91860469 |
| 96 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90593954 |
| 97 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.90258612 |
| 98 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.89697190 |
| 99 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.89447233 |
| 100 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.89440129 |
| 101 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.89440129 |
| 102 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88718277 |
| 103 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.88079266 |
| 104 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87811927 |
| 105 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87811927 |
| 106 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86508341 |
| 107 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.86175548 |
| 108 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86083345 |
| 109 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.85768575 |
| 110 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.85512347 |
| 111 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.85251340 |
| 112 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.84314486 |
| 113 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.84196357 |
| 114 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.83368540 |
| 115 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.82072113 |
| 116 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.81817500 |
| 117 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.81817500 |
| 118 | STAT3_23295773_ChIP-Seq_U87_Human | 0.81215707 |
| 119 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.81213699 |
| 120 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.80995332 |
| 121 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.80395308 |
| 122 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.80154074 |
| 123 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.79838441 |
| 124 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.79768104 |
| 125 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.77935013 |
| 126 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.77403764 |
| 127 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.77350923 |
| 128 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.77276681 |
| 129 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.77215610 |
| 130 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.76878460 |
| 131 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76862207 |
| 132 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.76853770 |
| 133 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.76556850 |
| 134 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75454051 |
| 135 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.74993150 |
| 136 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.74156027 |
| 137 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.71021022 |
| 138 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70627539 |
| 139 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.70367026 |
| 140 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70134189 |
| 141 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68405683 |
| 142 | AR_20517297_ChIP-Seq_VCAP_Human | 0.68315258 |
| 143 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.66852681 |
| 144 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.66447073 |
| 145 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.66030137 |
| 146 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.65775918 |
| 147 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.65678265 |
| 148 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.62738887 |
| 149 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.62408122 |
| 150 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.61324097 |
| 151 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.59959309 |
| 152 | GATA3_26560356_Chip-Seq_TH2_Human | 0.59809702 |
| 153 | GATA3_26560356_Chip-Seq_TH1_Human | 0.58641952 |
| 154 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.56646351 |
| 155 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.55886840 |
| 156 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.55342819 |
| 157 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.54269694 |
| 158 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.53028571 |
| 159 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.52921760 |
| 160 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.52090563 |
| 161 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.52029903 |
| 162 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.51939082 |
| 163 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.50867366 |
| 164 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.50720560 |
| 165 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.50480157 |
| 166 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.48942280 |
| 167 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.48349283 |
| 168 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.48125150 |
| 169 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.48058672 |
| 170 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.47511367 |
| 171 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.47346682 |
| 172 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.46984051 |
| 173 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.46910605 |
| 174 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.46903267 |
| 175 | MYB_26560356_Chip-Seq_TH1_Human | 0.46888000 |
| 176 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.46800921 |
| 177 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.46444767 |
| 178 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.45982320 |
| 179 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.45932388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.54092083 |
| 2 | MP0005360_urolithiasis | 6.88101684 |
| 3 | MP0002163_abnormal_gland_morphology | 6.11412747 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.81272251 |
| 5 | MP0005365_abnormal_bile_salt | 5.57860023 |
| 6 | MP0005275_abnormal_skin_tensile | 5.42534726 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 4.81810596 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 4.81405475 |
| 9 | MP0005171_absent_coat_pigmentation | 4.76881967 |
| 10 | MP0005379_endocrine/exocrine_gland_phen | 3.69673524 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 3.66041625 |
| 12 | MP0003252_abnormal_bile_duct | 3.53558268 |
| 13 | MP0010329_abnormal_lipoprotein_level | 3.48468604 |
| 14 | MP0009840_abnormal_foam_cell | 3.38486022 |
| 15 | MP0005083_abnormal_biliary_tract | 2.77114447 |
| 16 | MP0003195_calcinosis | 2.61227266 |
| 17 | MP0000569_abnormal_digit_pigmentation | 2.58706200 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.57915367 |
| 19 | MP0005332_abnormal_amino_acid | 2.53027153 |
| 20 | MP0001666_abnormal_nutrient_absorption | 2.44196267 |
| 21 | MP0005503_abnormal_tendon_morphology | 2.43407784 |
| 22 | MP0002060_abnormal_skin_morphology | 2.33534114 |
| 23 | MP0003279_aneurysm | 2.25580880 |
| 24 | MP0000609_abnormal_liver_physiology | 2.16539777 |
| 25 | MP0002118_abnormal_lipid_homeostasis | 2.03503436 |
| 26 | MP0002138_abnormal_hepatobiliary_system | 2.01128813 |
| 27 | MP0003868_abnormal_feces_composition | 1.94617562 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.94054949 |
| 29 | MP0000613_abnormal_salivary_gland | 1.91305205 |
| 30 | MP0008057_abnormal_DNA_replication | 1.90431977 |
| 31 | MP0008872_abnormal_physiological_respon | 1.90058008 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.79335456 |
| 33 | MP0001764_abnormal_homeostasis | 1.78885917 |
| 34 | MP0002332_abnormal_exercise_endurance | 1.75998459 |
| 35 | MP0001958_emphysema | 1.72193584 |
| 36 | MP0009697_abnormal_copulation | 1.66983642 |
| 37 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.66175870 |
| 38 | MP0005409_darkened_coat_color | 1.64899537 |
| 39 | MP0005076_abnormal_cell_differentiation | 1.51820930 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.48139853 |
| 41 | MP0000371_diluted_coat_color | 1.46351586 |
| 42 | MP0000003_abnormal_adipose_tissue | 1.46026762 |
| 43 | MP0004264_abnormal_extraembryonic_tissu | 1.44824524 |
| 44 | MP0002295_abnormal_pulmonary_circulatio | 1.44587259 |
| 45 | MP0000383_abnormal_hair_follicle | 1.44584333 |
| 46 | MP0003656_abnormal_erythrocyte_physiolo | 1.40205904 |
| 47 | MP0005464_abnormal_platelet_physiology | 1.39764759 |
| 48 | MP0005058_abnormal_lysosome_morphology | 1.35949362 |
| 49 | MP0002160_abnormal_reproductive_system | 1.34982872 |
| 50 | MP0009384_cardiac_valve_regurgitation | 1.34091923 |
| 51 | MP0009643_abnormal_urine_homeostasis | 1.32170210 |
| 52 | MP0008469_abnormal_protein_level | 1.31299479 |
| 53 | MP0003186_abnormal_redox_activity | 1.30428913 |
| 54 | MP0000598_abnormal_liver_morphology | 1.29396556 |
| 55 | MP0002108_abnormal_muscle_morphology | 1.28836425 |
| 56 | MP0004134_abnormal_chest_morphology | 1.26284072 |
| 57 | MP0000604_amyloidosis | 1.25599776 |
| 58 | MP0002089_abnormal_postnatal_growth/wei | 1.25573760 |
| 59 | MP0000749_muscle_degeneration | 1.21324670 |
| 60 | MP0010368_abnormal_lymphatic_system | 1.20805000 |
| 61 | MP0003724_increased_susceptibility_to | 1.20470869 |
| 62 | MP0003959_abnormal_lean_body | 1.15142387 |
| 63 | MP0002006_tumorigenesis | 1.14633558 |
| 64 | MP0005388_respiratory_system_phenotype | 1.13328804 |
| 65 | MP0002133_abnormal_respiratory_system | 1.13328804 |
| 66 | MP0000733_abnormal_muscle_development | 1.13088130 |
| 67 | MP0004381_abnormal_hair_follicle | 1.12894990 |
| 68 | MP0005375_adipose_tissue_phenotype | 1.12549839 |
| 69 | MP0009764_decreased_sensitivity_to | 1.09955633 |
| 70 | MP0005636_abnormal_mineral_homeostasis | 1.07352567 |
| 71 | MP0009763_increased_sensitivity_to | 1.07294673 |
| 72 | MP0001243_abnormal_dermal_layer | 1.04268099 |
| 73 | MP0003436_decreased_susceptibility_to | 1.03116799 |
| 74 | MP0000750_abnormal_muscle_regeneration | 1.02474387 |
| 75 | MP0009642_abnormal_blood_homeostasis | 1.01939538 |
| 76 | MP0002009_preneoplasia | 0.99294163 |
| 77 | MP0001853_heart_inflammation | 0.97126921 |
| 78 | MP0001216_abnormal_epidermal_layer | 0.95785643 |
| 79 | MP0002876_abnormal_thyroid_physiology | 0.94806317 |
| 80 | MP0006036_abnormal_mitochondrial_physio | 0.94304249 |
| 81 | MP0002933_joint_inflammation | 0.94200718 |
| 82 | MP0000767_abnormal_smooth_muscle | 0.94118227 |
| 83 | MP0002078_abnormal_glucose_homeostasis | 0.93404717 |
| 84 | MP0000372_irregular_coat_pigmentation | 0.93182159 |
| 85 | MP0003690_abnormal_glial_cell | 0.92922940 |
| 86 | MP0005647_abnormal_sex_gland | 0.92659935 |
| 87 | MP0006138_congestive_heart_failure | 0.92391654 |
| 88 | MP0001502_abnormal_circadian_rhythm | 0.92377456 |
| 89 | MP0004147_increased_porphyrin_level | 0.91157705 |
| 90 | MP0003300_gastrointestinal_ulcer | 0.91117754 |
| 91 | MP0010771_integument_phenotype | 0.89297295 |
| 92 | MP0005376_homeostasis/metabolism_phenot | 0.88052727 |
| 93 | MP0001879_abnormal_lymphatic_vessel | 0.87738310 |
| 94 | MP0004130_abnormal_muscle_cell | 0.87427875 |
| 95 | MP0000163_abnormal_cartilage_morphology | 0.86577547 |
| 96 | MP0000013_abnormal_adipose_tissue | 0.86535379 |
| 97 | MP0001835_abnormal_antigen_presentation | 0.86456821 |
| 98 | MP0002254_reproductive_system_inflammat | 0.86416333 |
| 99 | MP0001191_abnormal_skin_condition | 0.85890068 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 0.84912535 |
| 101 | MP0000747_muscle_weakness | 0.84584885 |
| 102 | MP0005389_reproductive_system_phenotype | 0.84198528 |
| 103 | MP0004142_abnormal_muscle_tone | 0.83492298 |
| 104 | MP0005535_abnormal_body_temperature | 0.83271259 |
| 105 | MP0002419_abnormal_innate_immunity | 0.82909406 |
| 106 | MP0003828_pulmonary_edema | 0.81198290 |
| 107 | MP0009785_altered_susceptibility_to | 0.81102126 |
| 108 | MP0003221_abnormal_cardiomyocyte_apopto | 0.81039188 |
| 109 | MP0005646_abnormal_pituitary_gland | 0.80315112 |
| 110 | MP0003172_abnormal_lysosome_physiology | 0.79789440 |
| 111 | MP0003453_abnormal_keratinocyte_physiol | 0.78689584 |
| 112 | MP0005023_abnormal_wound_healing | 0.77791156 |
| 113 | MP0003950_abnormal_plasma_membrane | 0.77396526 |
| 114 | MP0005334_abnormal_fat_pad | 0.76510021 |
| 115 | MP0005220_abnormal_exocrine_pancreas | 0.75937583 |
| 116 | MP0001845_abnormal_inflammatory_respons | 0.75060262 |
| 117 | MP0009765_abnormal_xenobiotic_induced | 0.74767712 |
| 118 | MP0005448_abnormal_energy_balance | 0.73072625 |
| 119 | MP0005666_abnormal_adipose_tissue | 0.72640135 |
| 120 | MP0010678_abnormal_skin_adnexa | 0.71799149 |
| 121 | MP0006276_abnormal_autonomic_nervous | 0.71760321 |
| 122 | MP0002971_abnormal_brown_adipose | 0.71730025 |
| 123 | MP0001440_abnormal_grooming_behavior | 0.71044371 |
| 124 | MP0004782_abnormal_surfactant_physiolog | 0.70499425 |
| 125 | MP0000639_abnormal_adrenal_gland | 0.69989708 |
| 126 | MP0002735_abnormal_chemical_nociception | 0.68666821 |
| 127 | MP0005025_abnormal_response_to | 0.67739789 |
| 128 | MP0004484_altered_response_of | 0.66422582 |
| 129 | MP0002269_muscular_atrophy | 0.65284627 |
| 130 | MP0003011_delayed_dark_adaptation | 0.64590171 |
| 131 | MP0005670_abnormal_white_adipose | 0.64361876 |
| 132 | MP0003638_abnormal_response/metabolism_ | 0.64153108 |
| 133 | MP0010386_abnormal_urinary_bladder | 0.64087381 |
| 134 | MP0003075_altered_response_to | 0.63309024 |
| 135 | MP0005266_abnormal_metabolism | 0.62983065 |
| 136 | MP0002733_abnormal_thermal_nociception | 0.62650309 |
| 137 | MP0006082_CNS_inflammation | 0.60884329 |
| 138 | MP0001756_abnormal_urination | 0.59709624 |
| 139 | MP0002136_abnormal_kidney_physiology | 0.59128231 |
| 140 | MP0002075_abnormal_coat/hair_pigmentati | 0.58622107 |
| 141 | MP0003045_fibrosis | 0.58570246 |
| 142 | MP0005166_decreased_susceptibility_to | 0.58348998 |
| 143 | MP0005408_hypopigmentation | 0.58088881 |
| 144 | MP0005451_abnormal_body_composition | 0.57820932 |
| 145 | MP0001544_abnormal_cardiovascular_syste | 0.57055464 |
| 146 | MP0005385_cardiovascular_system_phenoty | 0.57055464 |
| 147 | MP0001661_extended_life_span | 0.56508195 |
| 148 | MP0000367_abnormal_coat/_hair | 0.56070254 |
| 149 | MP0008770_decreased_survivor_rate | 0.56067683 |
| 150 | MP0002282_abnormal_trachea_morphology | 0.56059092 |
| 151 | MP0003953_abnormal_hormone_level | 0.55501813 |
| 152 | MP0008874_decreased_physiological_sensi | 0.54506725 |
| 153 | MP0010234_abnormal_vibrissa_follicle | 0.54494097 |
| 154 | MP0005167_abnormal_blood-brain_barrier | 0.53980920 |
| 155 | MP0000762_abnormal_tongue_morphology | 0.53934782 |
| 156 | MP0005620_abnormal_muscle_contractility | 0.51860827 |
| 157 | MP0003329_amyloid_beta_deposits | 0.51062998 |
| 158 | MP0009780_abnormal_chondrocyte_physiolo | 0.50713254 |
| 159 | MP0000249_abnormal_blood_vessel | 0.50390783 |
| 160 | MP0002166_altered_tumor_susceptibility | 0.49406438 |
| 161 | MP0002928_abnormal_bile_duct | 0.48793877 |
| 162 | MP0008961_abnormal_basal_metabolism | 0.48685964 |
| 163 | MP0005423_abnormal_somatic_nervous | 0.48588160 |
| 164 | MP0009115_abnormal_fat_cell | 0.47374451 |
| 165 | MP0010155_abnormal_intestine_physiology | 0.47332720 |
| 166 | MP0000230_abnormal_systemic_arterial | 0.46845769 |
| 167 | MP0001533_abnormal_skeleton_physiology | 0.45598321 |
| 168 | * MP0002723_abnormal_immune_serum | 0.44317160 |
| 169 | MP0003943_abnormal_hepatobiliary_system | 0.43693768 |
| 170 | MP0003705_abnormal_hypodermis_morpholog | 0.42715163 |
| 171 | * MP0001800_abnormal_humoral_immune | 0.42711059 |
| 172 | MP0003183_abnormal_peptide_metabolism | 0.42160903 |
| 173 | * MP0005000_abnormal_immune_tolerance | 0.41739874 |
| 174 | MP0005075_abnormal_melanosome_morpholog | 0.40973044 |
| 175 | MP0004043_abnormal_pH_regulation | 0.40425339 |
| 176 | MP0008873_increased_physiological_sensi | 0.39806174 |
| 177 | MP0006035_abnormal_mitochondrial_morpho | 0.39722967 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deformed sella turcica (HP:0002681) | 6.61378837 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.51401204 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.39755096 |
| 4 | Deep venous thrombosis (HP:0002625) | 6.12939200 |
| 5 | Diastasis recti (HP:0001540) | 5.72830028 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 5.67574214 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.65018596 |
| 8 | Broad ribs (HP:0000885) | 5.56313821 |
| 9 | J-shaped sella turcica (HP:0002680) | 5.55747211 |
| 10 | Vertebral arch anomaly (HP:0008438) | 5.54734879 |
| 11 | Hypobetalipoproteinemia (HP:0003563) | 5.51120946 |
| 12 | Xanthomatosis (HP:0000991) | 5.45741449 |
| 13 | Carpal bone hypoplasia (HP:0001498) | 5.38550985 |
| 14 | Flat acetabular roof (HP:0003180) | 5.36993916 |
| 15 | Abnormality of the sella turcica (HP:0002679) | 4.86029572 |
| 16 | Complement deficiency (HP:0004431) | 4.79773547 |
| 17 | Hyperlipoproteinemia (HP:0010980) | 4.70516757 |
| 18 | Neoplasm of the heart (HP:0100544) | 4.63039649 |
| 19 | Thoracolumbar scoliosis (HP:0002944) | 4.46454193 |
| 20 | Joint hemorrhage (HP:0005261) | 4.44750974 |
| 21 | Abnormality of glycolipid metabolism (HP:0010969) | 4.23992719 |
| 22 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.23992719 |
| 23 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.23992719 |
| 24 | Anomalous pulmonary venous return (HP:0010772) | 4.23739304 |
| 25 | Hyperammonemia (HP:0001987) | 4.23302405 |
| 26 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 4.15969369 |
| 27 | Abnormality of the odontoid process (HP:0003310) | 4.13806653 |
| 28 | Ketosis (HP:0001946) | 4.05472182 |
| 29 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 4.04566667 |
| 30 | Short 4th metacarpal (HP:0010044) | 4.04566667 |
| 31 | Aortic regurgitation (HP:0001659) | 3.99409261 |
| 32 | Hypolipoproteinemia (HP:0010981) | 3.99204483 |
| 33 | Abnormality of the common coagulation pathway (HP:0010990) | 3.97690630 |
| 34 | Hypoglycemic coma (HP:0001325) | 3.86895892 |
| 35 | Milia (HP:0001056) | 3.86395068 |
| 36 | Abnormality of the pulmonary veins (HP:0011718) | 3.86385316 |
| 37 | Hyperglycinemia (HP:0002154) | 3.84436853 |
| 38 | Fat malabsorption (HP:0002630) | 3.77566347 |
| 39 | Epidermoid cyst (HP:0200040) | 3.77092079 |
| 40 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.68646941 |
| 41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.67598466 |
| 42 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.64229579 |
| 43 | Genetic anticipation (HP:0003743) | 3.60843926 |
| 44 | Abnormality of the intrinsic pathway (HP:0010989) | 3.48969501 |
| 45 | Death in childhood (HP:0003819) | 3.48932512 |
| 46 | Conjugated hyperbilirubinemia (HP:0002908) | 3.48683819 |
| 47 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.48501848 |
| 48 | Abnormality of methionine metabolism (HP:0010901) | 3.47737642 |
| 49 | Abnormality of the lumbar spine (HP:0100712) | 3.46191087 |
| 50 | Short phalanx of the thumb (HP:0009660) | 3.44089017 |
| 51 | Abnormality of glycine metabolism (HP:0010895) | 3.39599972 |
| 52 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.39599972 |
| 53 | Abnormality of complement system (HP:0005339) | 3.39243766 |
| 54 | Hyperglycinuria (HP:0003108) | 3.37501810 |
| 55 | Hyperbilirubinemia (HP:0002904) | 3.37204373 |
| 56 | Hypoalphalipoproteinemia (HP:0003233) | 3.32568436 |
| 57 | Duplicated collecting system (HP:0000081) | 3.31071451 |
| 58 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.30368209 |
| 59 | Hypercholesterolemia (HP:0003124) | 3.28543412 |
| 60 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.27906799 |
| 61 | Hypoglycemic seizures (HP:0002173) | 3.25511987 |
| 62 | Flared iliac wings (HP:0002869) | 3.23398204 |
| 63 | Thickened calvaria (HP:0002684) | 3.23220838 |
| 64 | Oral leukoplakia (HP:0002745) | 3.22361954 |
| 65 | Broad alveolar ridges (HP:0000187) | 3.20601499 |
| 66 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.20113603 |
| 67 | Ketoacidosis (HP:0001993) | 3.16283055 |
| 68 | Systemic lupus erythematosus (HP:0002725) | 3.15909483 |
| 69 | Abnormality of the renal collecting system (HP:0004742) | 3.11793327 |
| 70 | Beaking of vertebral bodies (HP:0004568) | 3.10031533 |
| 71 | Vertebral fusion (HP:0002948) | 2.94512078 |
| 72 | Hypoplasia of the odontoid process (HP:0003311) | 2.92385453 |
| 73 | Delayed CNS myelination (HP:0002188) | 2.89054260 |
| 74 | Acanthocytosis (HP:0001927) | 2.87922512 |
| 75 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.87035691 |
| 76 | Abnormality of nucleobase metabolism (HP:0010932) | 2.84133971 |
| 77 | Medulloblastoma (HP:0002885) | 2.83751315 |
| 78 | Abnormality of the parietal bone (HP:0002696) | 2.83193943 |
| 79 | Slow saccadic eye movements (HP:0000514) | 2.82779786 |
| 80 | Abnormality of the 4th metacarpal (HP:0010012) | 2.82284368 |
| 81 | Hemiplegia (HP:0002301) | 2.79319559 |
| 82 | Gingival bleeding (HP:0000225) | 2.78077104 |
| 83 | Steatorrhea (HP:0002570) | 2.74685246 |
| 84 | Spontaneous abortion (HP:0005268) | 2.71680519 |
| 85 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.71495209 |
| 86 | Abnormality of serum amino acid levels (HP:0003112) | 2.67409389 |
| 87 | Metabolic acidosis (HP:0001942) | 2.64446333 |
| 88 | Glomerulonephritis (HP:0000099) | 2.64189817 |
| 89 | Menorrhagia (HP:0000132) | 2.62208747 |
| 90 | Abnormality of purine metabolism (HP:0004352) | 2.61016852 |
| 91 | Recurrent bronchitis (HP:0002837) | 2.58516867 |
| 92 | Right ventricular cardiomyopathy (HP:0011663) | 2.58483669 |
| 93 | Tongue fasciculations (HP:0001308) | 2.58047995 |
| 94 | Generalized aminoaciduria (HP:0002909) | 2.57080514 |
| 95 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 2.55490920 |
| 96 | Dicarboxylic aciduria (HP:0003215) | 2.55354989 |
| 97 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.55354989 |
| 98 | Myocardial infarction (HP:0001658) | 2.53306566 |
| 99 | Skin nodule (HP:0200036) | 2.50173019 |
| 100 | Arterial tortuosity (HP:0005116) | 2.45855054 |
| 101 | Wide intermamillary distance (HP:0006610) | 2.45833682 |
| 102 | Prominent occiput (HP:0000269) | 2.44690061 |
| 103 | Sensorimotor neuropathy (HP:0007141) | 2.43666554 |
| 104 | Hoarse voice (HP:0001609) | 2.43561449 |
| 105 | Down-sloping shoulders (HP:0200021) | 2.43449867 |
| 106 | Supernumerary ribs (HP:0005815) | 2.40528267 |
| 107 | Macroglossia (HP:0000158) | 2.40450124 |
| 108 | Spontaneous hematomas (HP:0007420) | 2.39007031 |
| 109 | Mitral stenosis (HP:0001718) | 2.37707453 |
| 110 | Muscle fibrillation (HP:0010546) | 2.37628801 |
| 111 | Hypoplastic pelvis (HP:0008839) | 2.36735690 |
| 112 | Muscle fiber splitting (HP:0003555) | 2.34293338 |
| 113 | Pathologic fracture (HP:0002756) | 2.34000465 |
| 114 | Abnormality of the thoracic spine (HP:0100711) | 2.31937215 |
| 115 | Lethargy (HP:0001254) | 2.28851461 |
| 116 | Hepatocellular carcinoma (HP:0001402) | 2.26774619 |
| 117 | Thrombophlebitis (HP:0004418) | 2.26117748 |
| 118 | Symptomatic seizures (HP:0011145) | 2.25516486 |
| 119 | Late onset (HP:0003584) | 2.25397512 |
| 120 | Gout (HP:0001997) | 2.25154358 |
| 121 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 2.24494465 |
| 122 | Hypoplastic scapulae (HP:0000882) | 2.24494465 |
| 123 | Supernumerary bones of the axial skeleton (HP:0009144) | 2.24302375 |
| 124 | Ovoid vertebral bodies (HP:0003300) | 2.21639453 |
| 125 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.20661305 |
| 126 | Vacuolated lymphocytes (HP:0001922) | 2.17957420 |
| 127 | Cholecystitis (HP:0001082) | 2.17906187 |
| 128 | Abnormal gallbladder physiology (HP:0012438) | 2.17906187 |
| 129 | Pancreatitis (HP:0001733) | 2.17842657 |
| 130 | Abnormal gallbladder morphology (HP:0012437) | 2.16871154 |
| 131 | Protuberant abdomen (HP:0001538) | 2.16691442 |
| 132 | Impaired platelet aggregation (HP:0003540) | 2.14961859 |
| 133 | Abnormal platelet function (HP:0011869) | 2.14961859 |
| 134 | Calf muscle hypertrophy (HP:0008981) | 2.14482694 |
| 135 | Vascular tortuosity (HP:0004948) | 2.12014542 |
| 136 | Increased connective tissue (HP:0009025) | 2.11467486 |
| 137 | Neoplasm of the oral cavity (HP:0100649) | 2.11370836 |
| 138 | Spastic diplegia (HP:0001264) | 2.11120531 |
| 139 | Thoracic kyphosis (HP:0002942) | 2.11115245 |
| 140 | Epistaxis (HP:0000421) | 2.09112751 |
| 141 | Esophageal varix (HP:0002040) | 2.07759823 |
| 142 | Cholelithiasis (HP:0001081) | 2.07696034 |
| 143 | Dysostosis multiplex (HP:0000943) | 2.06288696 |
| 144 | Abnormality of DNA repair (HP:0003254) | 2.03671281 |
| 145 | Cerebellar dysplasia (HP:0007033) | 2.03530518 |
| 146 | Abnormality of the wing of the ilium (HP:0011867) | 2.01269581 |
| 147 | Irritability (HP:0000737) | 2.00091726 |
| 148 | Abnormality of the alveolar ridges (HP:0006477) | 1.98842509 |
| 149 | Poikilocytosis (HP:0004447) | 1.97649416 |
| 150 | Abnormal auditory evoked potentials (HP:0006958) | 1.97447976 |
| 151 | Vascular calcification (HP:0004934) | 1.96932141 |
| 152 | Neonatal onset (HP:0003623) | 1.96425124 |
| 153 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.95843001 |
| 154 | Mucopolysacchariduria (HP:0008155) | 1.95843001 |
| 155 | Opisthotonus (HP:0002179) | 1.95717818 |
| 156 | Cerebral edema (HP:0002181) | 1.95363132 |
| 157 | Hemorrhage of the eye (HP:0011885) | 1.95016093 |
| 158 | Hypoplasia of the iris (HP:0007676) | 1.93173971 |
| 159 | Amyloidosis (HP:0011034) | 1.90166499 |
| 160 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.89644849 |
| 161 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.89644849 |
| 162 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.89644849 |
| 163 | Vomiting (HP:0002013) | 1.89552809 |
| 164 | Clumsiness (HP:0002312) | 1.87777629 |
| 165 | Abnormality of the humerus (HP:0003063) | 1.87407841 |
| 166 | Purpura (HP:0000979) | 1.87078851 |
| 167 | Brushfield spots (HP:0001088) | 1.86926663 |
| 168 | Impaired smooth pursuit (HP:0007772) | 1.86653447 |
| 169 | Abnormality of the nasal septum (HP:0000419) | 1.86297963 |
| 170 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.85318218 |
| 171 | Severe short stature (HP:0003510) | 1.85309040 |
| 172 | Progressive cerebellar ataxia (HP:0002073) | 1.84582107 |
| 173 | Neoplasm of striated muscle (HP:0009728) | 1.84565152 |
| 174 | Pulmonary embolism (HP:0002204) | 1.84474626 |
| 175 | Elevated hepatic transaminases (HP:0002910) | 1.83426038 |
| 176 | Short ribs (HP:0000773) | 1.82715024 |
| 177 | Lack of skin elasticity (HP:0100679) | 1.82402716 |
| 178 | Skin pits (HP:0100276) | 1.81906819 |
| 179 | Ureteral obstruction (HP:0006000) | 1.80763502 |
| 180 | Nephritis (HP:0000123) | 1.80533724 |
| 181 | Abnormality of proline metabolism (HP:0010907) | 1.78716720 |
| 182 | Hydroxyprolinuria (HP:0003080) | 1.78716720 |
| 183 | Abnormality of the gallbladder (HP:0005264) | 1.78597689 |
| 184 | Abnormality of the upper arm (HP:0001454) | 1.78249136 |
| 185 | Enlarged kidneys (HP:0000105) | 1.77984084 |
| 186 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.77499430 |
| 187 | Abnormality of the epiphyses of the phalanges of the hand (HP:0005920) | 1.77043239 |
| 188 | Abnormal hand bone ossification (HP:0010660) | 1.74626058 |
| 189 | Hypochromic microcytic anemia (HP:0004840) | 1.74445311 |
| 190 | Dry hair (HP:0011359) | 1.71431552 |
| 191 | Cavernous hemangioma (HP:0001048) | 1.69338558 |
| 192 | Palpebral edema (HP:0100540) | 1.68768371 |
| 193 | Visual hallucinations (HP:0002367) | 1.66901147 |
| 194 | Hemivertebrae (HP:0002937) | 1.64604770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.89752006 |
| 2 | KIT | 3.09514619 |
| 3 | TAOK3 | 3.07687523 |
| 4 | SIK1 | 3.00510180 |
| 5 | FLT3 | 2.99106143 |
| 6 | ERN1 | 2.89579305 |
| 7 | FGFR4 | 2.88230061 |
| 8 | TIE1 | 2.58980108 |
| 9 | NEK9 | 2.56939589 |
| 10 | INSRR | 2.44113136 |
| 11 | TYK2 | 2.43035376 |
| 12 | TLK1 | 2.11285080 |
| 13 | TGFBR2 | 2.07595655 |
| 14 | MAP3K4 | 2.00331332 |
| 15 | PKN2 | 1.94695918 |
| 16 | MAP4K1 | 1.94154808 |
| 17 | CSF1R | 1.92528850 |
| 18 | WNK1 | 1.79732119 |
| 19 | CASK | 1.68152324 |
| 20 | SCYL2 | 1.67754411 |
| 21 | CDK12 | 1.67474731 |
| 22 | TBK1 | 1.67414051 |
| 23 | ACVR1B | 1.61464851 |
| 24 | MAPK11 | 1.59350888 |
| 25 | STK4 | 1.58383146 |
| 26 | MAP2K4 | 1.52601646 |
| 27 | PIK3CG | 1.51074037 |
| 28 | CDK19 | 1.51058401 |
| 29 | ADRBK2 | 1.50373875 |
| 30 | IRAK3 | 1.47625349 |
| 31 | JAK1 | 1.47316718 |
| 32 | PRPF4B | 1.46340053 |
| 33 | PTK2B | 1.45682742 |
| 34 | TEC | 1.41112693 |
| 35 | CAMKK2 | 1.37541347 |
| 36 | BLK | 1.34316484 |
| 37 | DAPK2 | 1.33855498 |
| 38 | MAP3K6 | 1.33337824 |
| 39 | SGK494 | 1.30138511 |
| 40 | SGK223 | 1.30138511 |
| 41 | BTK | 1.29204028 |
| 42 | IRAK2 | 1.27985661 |
| 43 | MAPK15 | 1.27139478 |
| 44 | JAK2 | 1.24287977 |
| 45 | MATK | 1.20067449 |
| 46 | EPHA3 | 1.19705993 |
| 47 | MAP3K2 | 1.18685995 |
| 48 | AKT3 | 1.18004510 |
| 49 | ERBB4 | 1.17285758 |
| 50 | CCNB1 | 1.14230020 |
| 51 | MAP3K12 | 1.14048066 |
| 52 | MAP3K11 | 1.12884798 |
| 53 | CAMK1D | 1.09864609 |
| 54 | PDK4 | 1.04876417 |
| 55 | PDK3 | 1.04876417 |
| 56 | SYK | 1.04515176 |
| 57 | PBK | 1.03323357 |
| 58 | EPHA2 | 0.99097647 |
| 59 | DAPK3 | 0.99016693 |
| 60 | GRK6 | 0.95920660 |
| 61 | MAPKAPK5 | 0.95047271 |
| 62 | GRK1 | 0.94958155 |
| 63 | JAK3 | 0.94622378 |
| 64 | MAP3K14 | 0.94410984 |
| 65 | NUAK1 | 0.94213647 |
| 66 | PRKAA2 | 0.94040068 |
| 67 | MAP3K7 | 0.91877208 |
| 68 | FRK | 0.91543370 |
| 69 | ADRBK1 | 0.90094362 |
| 70 | MAP2K3 | 0.89922999 |
| 71 | MST1R | 0.89789182 |
| 72 | TRIB3 | 0.88812935 |
| 73 | MAP3K1 | 0.88799030 |
| 74 | TAOK2 | 0.87398882 |
| 75 | TGFBR1 | 0.87128769 |
| 76 | ZAK | 0.87021898 |
| 77 | PTK6 | 0.86055091 |
| 78 | MYLK | 0.84858888 |
| 79 | MAPK4 | 0.83486231 |
| 80 | GRK5 | 0.82822668 |
| 81 | RPS6KA5 | 0.81852911 |
| 82 | STK38 | 0.81679552 |
| 83 | DAPK1 | 0.80305271 |
| 84 | DYRK1B | 0.79980554 |
| 85 | SGK2 | 0.79564621 |
| 86 | CAMKK1 | 0.75924949 |
| 87 | HIPK2 | 0.75646377 |
| 88 | STK38L | 0.75181633 |
| 89 | ZAP70 | 0.71682673 |
| 90 | RPS6KA6 | 0.71447597 |
| 91 | PIM1 | 0.71340041 |
| 92 | PRKCH | 0.70660770 |
| 93 | IKBKE | 0.70652192 |
| 94 | RET | 0.70317556 |
| 95 | CAMK1G | 0.67927504 |
| 96 | LYN | 0.67382083 |
| 97 | PRKAA1 | 0.67322548 |
| 98 | TRPM7 | 0.65702330 |
| 99 | TAF1 | 0.65233023 |
| 100 | IRAK4 | 0.65204517 |
| 101 | PDGFRB | 0.64704884 |
| 102 | GRK7 | 0.59489628 |
| 103 | RPS6KL1 | 0.54888231 |
| 104 | RPS6KC1 | 0.54888231 |
| 105 | PDK1 | 0.54561281 |
| 106 | MAP2K7 | 0.54510615 |
| 107 | PRKACG | 0.53802055 |
| 108 | MET | 0.53022551 |
| 109 | SGK3 | 0.52318627 |
| 110 | MTOR | 0.51712611 |
| 111 | PRKCI | 0.51125645 |
| 112 | ERBB2 | 0.51064157 |
| 113 | IGF1R | 0.50548947 |
| 114 | ITK | 0.50162562 |
| 115 | LATS1 | 0.49384105 |
| 116 | FES | 0.49026505 |
| 117 | OBSCN | 0.48400173 |
| 118 | TNIK | 0.48112552 |
| 119 | SGK1 | 0.47199590 |
| 120 | KDR | 0.46948503 |
| 121 | WEE1 | 0.46197256 |
| 122 | BRD4 | 0.46189872 |
| 123 | CDK6 | 0.45915287 |
| 124 | PAK3 | 0.45294595 |
| 125 | MAP3K13 | 0.45263502 |
| 126 | RIPK1 | 0.45138023 |
| 127 | LCK | 0.44968417 |
| 128 | ICK | 0.44889590 |
| 129 | MAP3K3 | 0.44812006 |
| 130 | EGFR | 0.43704004 |
| 131 | EEF2K | 0.42182755 |
| 132 | MAP2K1 | 0.42131390 |
| 133 | BMPR1B | 0.41935118 |
| 134 | RIPK4 | 0.41745872 |
| 135 | MAP2K6 | 0.41578520 |
| 136 | NME2 | 0.40808484 |
| 137 | STK3 | 0.40632592 |
| 138 | PRKCQ | 0.39701288 |
| 139 | MAPK3 | 0.39673151 |
| 140 | VRK1 | 0.39654545 |
| 141 | CSK | 0.39308555 |
| 142 | IRAK1 | 0.38720713 |
| 143 | FGFR3 | 0.38494199 |
| 144 | KSR2 | 0.37581162 |
| 145 | PDPK1 | 0.36972256 |
| 146 | BRSK2 | 0.36643394 |
| 147 | SIK3 | 0.36020171 |
| 148 | STK10 | 0.35800767 |
| 149 | MST4 | 0.33717140 |
| 150 | TTN | 0.33565711 |
| 151 | CAMK4 | 0.32723639 |
| 152 | MARK2 | 0.32608684 |
| 153 | PHKG2 | 0.31769623 |
| 154 | PHKG1 | 0.31769623 |
| 155 | PRKD2 | 0.31705214 |
| 156 | CAMK1 | 0.31532612 |
| 157 | MAPK12 | 0.31492326 |
| 158 | RPS6KA2 | 0.30624203 |
| 159 | STK24 | 0.30219879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 4.58121035 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.35771056 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.62890823 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.31193455 |
| 5 | Alcoholism_Homo sapiens_hsa05034 | 3.27975100 |
| 6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.92607525 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.82200616 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.81144241 |
| 9 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.74343011 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.68708049 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.62299804 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46837680 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.44759382 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.42601686 |
| 15 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.34956116 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.25596972 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.21429353 |
| 18 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.07456379 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.06892567 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.05769119 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.03118533 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.96246478 |
| 23 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.94253527 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.91332304 |
| 25 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.89265165 |
| 26 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.86046186 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.81237219 |
| 28 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.74774920 |
| 29 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.74470397 |
| 30 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.73264445 |
| 31 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72033528 |
| 32 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.66049395 |
| 33 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.64386097 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.60997521 |
| 35 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.56146286 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53993420 |
| 37 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.52984624 |
| 38 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.52731608 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.47869820 |
| 40 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.47082325 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46522947 |
| 42 | Retinol metabolism_Homo sapiens_hsa00830 | 1.43384190 |
| 43 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.42513068 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.40920599 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.40518765 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.39788808 |
| 47 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.39503991 |
| 48 | ABC transporters_Homo sapiens_hsa02010 | 1.39103037 |
| 49 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.35166074 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.34594129 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.34580338 |
| 52 | Renin secretion_Homo sapiens_hsa04924 | 1.32487120 |
| 53 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.31628781 |
| 54 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.31332408 |
| 55 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30118797 |
| 56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.28623193 |
| 57 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28153876 |
| 58 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.25813998 |
| 59 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.20605579 |
| 60 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.19095606 |
| 61 | Gap junction_Homo sapiens_hsa04540 | 1.18886552 |
| 62 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.16377161 |
| 63 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.16321205 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.15729085 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 1.14247662 |
| 66 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.12427102 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.10124579 |
| 68 | Taste transduction_Homo sapiens_hsa04742 | 1.04783076 |
| 69 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.04767663 |
| 70 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.03944569 |
| 71 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.03554825 |
| 72 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.03182722 |
| 73 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.01577842 |
| 74 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.99733023 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.99592022 |
| 76 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.97716011 |
| 77 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.97611289 |
| 78 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.96794806 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.96200165 |
| 80 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.95735547 |
| 81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95482846 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.94055120 |
| 83 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.93684395 |
| 84 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.92654968 |
| 85 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.92641846 |
| 86 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.91854670 |
| 87 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.91426284 |
| 88 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.90143205 |
| 89 | Morphine addiction_Homo sapiens_hsa05032 | 0.89649552 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.89257804 |
| 91 | Focal adhesion_Homo sapiens_hsa04510 | 0.88170159 |
| 92 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86682000 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85067972 |
| 94 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.84770148 |
| 95 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.83665581 |
| 96 | Melanoma_Homo sapiens_hsa05218 | 0.83614645 |
| 97 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.83409196 |
| 98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83205664 |
| 99 | Glioma_Homo sapiens_hsa05214 | 0.81162738 |
| 100 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80567639 |
| 101 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.79819591 |
| 102 | Leishmaniasis_Homo sapiens_hsa05140 | 0.79073920 |
| 103 | Tuberculosis_Homo sapiens_hsa05152 | 0.78739654 |
| 104 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78342567 |
| 105 | Prostate cancer_Homo sapiens_hsa05215 | 0.77772726 |
| 106 | Insulin secretion_Homo sapiens_hsa04911 | 0.77473209 |
| 107 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.77385506 |
| 108 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.77280205 |
| 109 | Melanogenesis_Homo sapiens_hsa04916 | 0.76970402 |
| 110 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.76855149 |
| 111 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.75904493 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.75356109 |
| 113 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.75140305 |
| 114 | Lysine degradation_Homo sapiens_hsa00310 | 0.72914729 |
| 115 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72637104 |
| 116 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.72313426 |
| 117 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71458800 |
| 118 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.71421728 |
| 119 | Circadian rhythm_Homo sapiens_hsa04710 | 0.70215296 |
| 120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69975962 |
| 121 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.68997810 |
| 122 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.68609251 |
| 123 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67771870 |
| 124 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.66259737 |
| 125 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.65770951 |
| 126 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64858729 |
| 127 | Sulfur relay system_Homo sapiens_hsa04122 | 0.63966750 |
| 128 | Pathways in cancer_Homo sapiens_hsa05200 | 0.63640863 |
| 129 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.63208326 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.63196463 |
| 131 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.62773278 |
| 132 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.60565510 |
| 133 | Bladder cancer_Homo sapiens_hsa05219 | 0.60555185 |
| 134 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57776796 |
| 135 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57730149 |
| 136 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.57428306 |
| 137 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.57076228 |
| 138 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56820207 |
| 139 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.56667288 |
| 140 | Galactose metabolism_Homo sapiens_hsa00052 | 0.56251217 |
| 141 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.55824921 |
| 142 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55635508 |
| 143 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.54975196 |
| 144 | Malaria_Homo sapiens_hsa05144 | 0.54062487 |
| 145 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.54031392 |
| 146 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51408726 |
| 147 | GABAergic synapse_Homo sapiens_hsa04727 | 0.50859705 |
| 148 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.50111121 |
| 149 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.48728101 |
| 150 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.48576510 |
| 151 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45712664 |
| 152 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.45339380 |
| 153 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34037154 |
| 154 | Prion diseases_Homo sapiens_hsa05020 | 0.30387011 |
| 155 | Lysosome_Homo sapiens_hsa04142 | 0.30335773 |
| 156 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.28794874 |
| 157 | Insulin resistance_Homo sapiens_hsa04931 | 0.27660595 |
| 158 | Other glycan degradation_Homo sapiens_hsa00511 | 0.24403530 |
| 159 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.19258995 |
| 160 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15049577 |
| 161 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.06066695 |
| 162 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.05454156 |
| 163 | Pertussis_Homo sapiens_hsa05133 | 0.03681330 |
| 164 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.02193416 |
| 165 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.01529141 |
| 166 | Phagosome_Homo sapiens_hsa04145 | -0.1426279 |
| 167 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1336292 |
| 168 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.1260773 |
| 169 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.1063299 |
| 170 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1028300 |
| 171 | Protein export_Homo sapiens_hsa03060 | -0.0963827 |
| 172 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0894218 |
| 173 | Legionellosis_Homo sapiens_hsa05134 | -0.0891879 |
| 174 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | -0.0879610 |
| 175 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0862906 |
| 176 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | -0.0813507 |
| 177 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | -0.0759267 |
| 178 | Hepatitis C_Homo sapiens_hsa05160 | -0.0716252 |
| 179 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.0634737 |
| 180 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0601076 |
| 181 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0585499 |
| 182 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0166207 |

